US Stock MarketDetailed Quotes
TYRA TYRA BIOSCIENCES, INC.
- 16.420
- +0.030+0.18%
Close Nov 4 16:00 ET
- 16.950
- +0.530+3.23%
Post 17:12 ET
867.08MMarket Cap-9658P/E (TTM)
17.080High16.190Low281.36KVolume17.080Open16.390Pre Close4.64MTurnover2.74%Turnover RatioLossP/E (Static)52.81MShares29.60052wk High2.31P/B168.59MFloat Cap10.60052wk Low--Dividend TTM10.27MShs Float31.360Historical High--Div YieldTTM5.43%Amplitude4.930Historical Low16.497Avg Price1Lot Size
TYRA BIOSCIENCES, INC. Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -6.69%-10.26M | -123.70%-22.03M | 0.29%-50.14M | -12.95%-13.53M | -40.39%-17.15M | 43.99%-9.62M | -10.33%-9.85M | -111.77%-50.29M | -32.70%-11.98M | -118.93%-12.21M |
| Net income from continuing operations | -40.91%-18.7M | -53.13%-18.19M | -24.96%-69.13M | -77.05%-22.83M | -69.09%-21.15M | 12.08%-13.27M | 19.87%-11.88M | -110.41%-55.33M | -29.86%-12.9M | -88.30%-12.51M |
| Operating gains losses | ---- | ---- | 33.33%4K | --0 | ---- | ---- | ---- | 0.00%3K | --0 | --1K |
| Depreciation and amortization | 41.57%126K | 46.99%122K | 19.26%353K | 24.39%102K | -3.66%79K | 30.88%89K | 29.69%83K | 111.43%296K | 64.00%82K | 100.00%82K |
| Change In working capital | 455.73%5.77M | -1,316.98%-6.84M | 208.77%6.36M | 401.40%6.26M | 43.73%-453K | 121.52%1.04M | -125.93%-483K | -1,115.59%-5.85M | -104.33%-2.08M | -256.61%-805K |
| -Change in prepaid assets | 2,070.47%3.8M | -102.81%-43K | 65.73%-2.82M | 147.41%1.09M | -508.70%-5.25M | 96.41%-193K | 411.71%1.53M | -290.80%-8.24M | -92.53%-2.29M | -13.27%-862K |
| -Change in payables and accrued expense | 16.15%1.94M | -241.54%-6.91M | 297.50%9.37M | 2,352.17%5.08M | 9,572.92%4.64M | 208.49%1.67M | -229.62%-2.02M | 57.98%2.36M | 115.63%207K | -96.08%48K |
| -Change in other working capital | 106.59%29K | 1,066.67%105K | -647.06%-186K | 840.00%94K | 1,577.78%151K | -4,100.00%-440K | 125.00%9K | -74.81%34K | -87.34%10K | -82.00%9K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -6.69%-10.26M | -123.70%-22.03M | 0.29%-50.14M | -12.95%-13.53M | -40.39%-17.15M | 43.99%-9.62M | -10.33%-9.85M | -111.77%-50.29M | -32.70%-11.98M | -118.93%-12.21M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -337,088.37%-144.99M | 44,180.49%18.07M | -25,768.52%-144.61M | -687,700.00%-144.44M | -72.92%-83K | 82.87%-43K | 82.85%-41K | 13.33%-559K | 80.00%-21K | 80.00%-48K |
| Net PPE purchase and sale | -993.02%-470K | -231.71%-136K | -37.75%-770K | -2,771.43%-603K | -72.92%-83K | 82.87%-43K | 82.85%-41K | 13.33%-559K | 80.00%-21K | 80.00%-48K |
| Net investment purchase and sale | ---144.52M | --18.21M | ---143.84M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -337,088.37%-144.99M | 44,180.49%18.07M | -25,768.52%-144.61M | -687,700.00%-144.44M | -72.92%-83K | 82.87%-43K | 82.85%-41K | 13.33%-559K | 80.00%-21K | 80.00%-48K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0.81%373K | 53,175.27%200.32M | 143.20%1.54M | 10,700.00%324K | 28.30%467K | 1,270.37%370K | 57.98%376K | -99.80%632K | 100.20%3K | -99.80%364K |
| Net common stock issuance | ---251K | --199.83M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | 68.65%624K | 28.72%484K | 143.20%1.54M | 10,700.00%324K | 28.30%467K | 1,270.37%370K | 57.98%376K | 22.96%632K | --3K | --364K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 0.81%373K | 53,175.27%200.32M | 143.20%1.54M | 10,700.00%324K | 28.30%467K | 1,270.37%370K | 57.98%376K | -99.80%632K | 100.20%3K | -99.80%364K |
| Net cash flow | ||||||||||
| Beginning cash position | 5.22%255.37M | -76.60%59.01M | -16.60%252.21M | -18.00%216.65M | -15.46%233.41M | -17.31%242.7M | -16.60%252.21M | 1,855.29%302.43M | -15.61%264.21M | 103.85%276.11M |
| Current changes in cash | -1,567.48%-154.88M | 2,164.34%196.36M | -284.78%-193.21M | -1,213.94%-157.65M | -40.90%-16.76M | 46.60%-9.29M | -6.57%-9.51M | -117.50%-50.21M | -12.75%-12M | -106.70%-11.9M |
| End cash Position | -56.95%100.49M | 5.22%255.37M | -76.60%59.01M | -76.60%59.01M | -18.00%216.65M | -15.46%233.41M | -17.31%242.7M | -16.60%252.21M | -16.60%252.21M | -15.61%264.21M |
| Free cash flow | -11.08%-10.73M | -124.15%-22.16M | -0.13%-50.91M | -17.78%-14.14M | -40.52%-17.23M | 44.55%-9.66M | -7.90%-9.89M | -108.33%-50.84M | -31.40%-12M | -110.15%-12.26M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data